MEI Pharma, a biopharmaceutical company listed on the Nasdaq exchange, has made a significant foray into the cryptocurrency market, announcing a strategic allocation of $100 million to its corporate treasury in Litecoin (LTC). This bold move positions MEI Pharma among a growing cohort of publicly traded companies exploring digital assets as a hedge against inflation, … Continue reading Nasdaq Pharma Giant MEI Pharma Commits $100M to Litecoin Treasury, Signaling Shifting Corporate Strategy